Science Explorer Back to mapMap
Discussion
Nonprofit · Omaha · United States

Missouri Valley Cancer Consortium

Research works
19
▼ 100% vs 2018-21
Citations
1.1k
59.7 per fractional work
Top-10% rate
30.1%
all institutions 10.0%
Open access
27%
world 40%
International
11%
world 18%

Not ranked overall: Missouri Valley Cancer Consortium is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Missouri Valley Cancer Consortium work in?

In all years, 82% of research at Missouri Valley Cancer Consortium is in Health Sciences, 13% in Life Sciences. Its largest fields are Medicine (81%), Biochemistry, Genetics and Molecular Biology (11%), Economics, Econometrics and Finance (4%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 82.2% of its workMedicine: 16 fractional works · 81.2% of its workOncology: 6 fractional works · 32.5% of its workPulmonary and Respiratory Medicine: 4 fractional works · 19.0% of its workPhysiology: 1 fractional works · 5.1% of its workDermatology: 1 fractional works · 4.4% of its workSurgery: 1 fractional works · 3.5% of its workEpidemiology: 1 fractional works · 3.4% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.8% of its workHematology: 0 fractional works · 2.4% of its workPathology and Forensic Medicine: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 1.0% of its workNutrition and Dietetics: 0 fractional works · 1.0% of its workLife Sciences: 3 fractional works · 13.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 11.2% of its workCancer Research: 1 fractional works · 4.2% of its workMolecular Biology: 1 fractional works · 3.7% of its workGenetics: 1 fractional works · 3.1% of its workBiotechnology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 1.2% of its workImmunology: 0 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 3.6% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.6% of its workEconomics and Econometrics: 1 fractional works · 3.6% of its workPhysical Sciences: 0 fractional works · 1.0% of its workPhysics and Astronomy: 0 fractional works · 0.9% of its workRadiation: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 0.2% of its workALL ITS WORKMissouri ValleyCancer Consortium19fractional works, all years
Life Sciences13%Physical Sciences1%Health Sciences82%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine1681.2%
    2. Nursing01.0%
    1. Biochemistry, Genetics and Molecular Biology211.2%
    2. Immunology and Microbiology01.2%
    3. Pharmacology, Toxicology and Pharmaceutics00.5%
    4. Neuroscience00.2%
    1. Economics, Econometrics and Finance13.6%
    1. Physics and Astronomy00.9%
    2. Chemistry00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Missouri Valley Cancer Consortium?

    Ranked on the quality score, Gamini S. Soori lead among researchers whose main affiliation is Missouri Valley Cancer Consortium.

    1. 1 Gamini S. Soori United States · #256,672 worldwide 6k citations · 95 works
    All ranked researchers at Missouri Valley Cancer Consortium

    What are the most cited papers from Missouri Valley Cancer Consortium?

    The most cited paper from Missouri Valley Cancer Consortium is "Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial" (Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al., 2000), with 739 citations. Next come "Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study" (364) and "Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy" (362).

    Most cited papers
    #PaperReleasedCitations
    1 Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al. · The Lancet Dec 2000 739
    2 Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi et al. · Journal of Clinical Oncology 15 Jan 2002 364
    3 Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy Ravi D. Rao, John C. Michalak, Jeff A. Sloan et al. · Cancer 12 Sep 2007 362
    4 Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial Carmen Joseph Allegra et al. · JNCI Journal of the National Cancer Institute Open access 14 Sep 2015 331
    5 An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi et al. · Journal of Clinical Oncology 15 Jun 2004 299
    All 74 most cited papers, with filters and sorting

    Which research topics does Missouri Valley Cancer Consortium publish most on?

    By volume: Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Chemotherapy-related skin toxicity.

    1. 1 Cancer Treatment and Pharmacology Oncology 3 works
    2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
    3. 3 Lung Cancer Research Studies Oncology 1 works
    4. 4 Chemotherapy-related skin toxicity Dermatology 1 works
    5. 5 Breast Cancer Treatment Studies Cancer Research 1 works
    6. 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
    7. 7 Estrogen and related hormone effects Genetics 1 works
    8. 8 Cancer survivorship and care Oncology 1 works
    9. 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
    10. 10 Colorectal Cancer Treatments and Studies Oncology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available26.8%not open73.2%

    World: 40% of research is openly available.

    with international co-authors11.0%domestic only89.0%

    World: 18% is written across borders.

    How has Missouri Valley Cancer Consortium's research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    20002005201020152020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Missouri Valley Cancer Consortium as a percentage of every work published that year, 0.0000029% in 2018.

    0.00010%0.00020%0.00030%Missouri Valley Cancer Consortium0.0000033% in 2021200020102020

    Fractional works of Missouri Valley Cancer Consortium over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Omaha

    All research institutions in Omaha

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Missouri Valley Cancer Consortium. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.